Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Evommune (EVMN) Shares Outstanding (2024 - 2025)

Evommune (EVMN) has disclosed Shares Outstanding for 2 consecutive years, with $31.5 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 1931.95% to $31.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $31.5 million through Dec 2025, up 1931.95% year-over-year, with the annual reading at $31.5 million for FY2025, 1931.95% up from the prior year.
  • Shares Outstanding for Q4 2025 was $31.5 million at Evommune, up from $1.6 million in the prior quarter.
  • The five-year high for Shares Outstanding was $31.5 million in Q4 2025, with the low at $1.5 million in Q3 2024.